⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1359054 | 0.91 | ALDH1A1 (0.41) | — | |
| SCHEMBL780105 | 0.81 | ACHE (0.44) | — | |
| SCHEMBL83808 | 0.81 | MAPT (0.47) | — | |
| SCHEMBL577210 | 0.79 | ACHE (0.46) | — | |
| SCHEMBL482240 | 0.79 | HAO1 (0.55) | — | |
| SCHEMBL11200483 | 0.77 | — | — | |
| SCHEMBL1615865 | 0.77 | — | — | |
| SCHEMBL16404706 | 0.75 | — | — | |
| SCHEMBL10940299 | 0.75 | — | — | |
| SCHEMBL1145703 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184550-B | Preparation method of 3-fluorobenzenesulfonyl chloride | 爱斯特（成都）生物制药股份有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118184550-A | Preparation method of 3-fluorobenzenesulfonyl chloride | 爱斯特（成都）生物制药股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-10954229-B2 | GPR119 agonist compounds | MANKIND PHARMA LTD. (IN) | 2021-03-23 | — | — | US | claimed |
| US-20200317661-A1 | NOVEL GPR119 AGONIST COMPOUNDS | MANKIND PHARMA LTD. (IN) | 2020-10-08 | — | — | US | claimed |
| US-12497396-B2 | Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancers | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2025-12-16 | — | — | US | disclosed |
| CN-118745176-A | Nitrogen-containing heterocyclic derivative regulator, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2024-10-08 | — | — | CN | disclosed |
| CN-118745177-A | Nitrogen-containing heterocyclic derivative regulator, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2024-10-08 | — | — | CN | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| CN-113423703-B | Nitrogen-containing heterocyclic derivative regulator, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118184550-B | Preparation method of 3-fluorobenzenesulfonyl chloride | 爱斯特（成都）生物制药股份有限公司 | 2024-07-30 | — | — | CN | disclosed |
| EP-4400500-A1 | HALOGEN-SUBSTITUTED PYRIDAZINONE COMPOUND AND APPLICATION THEREOF | Medshine Discovery Inc. (CN) | 2024-07-17 | — | — | EP | disclosed |
| US-5854277-A | Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors | BAYER CORPORATION (US) | 1998-12-29 | — | — | US | disclosed |
| EP-0276124-B1 | PROSTAGLANDIN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | Sankyo Company Limited (JP) | 1992-05-20 | — | — | EP | disclosed |
| US-4981872-A | ANTIULCER | SANKYO COMPANY LIMITED (JP) | 1991-01-01 | — | — | US | disclosed |
| EP-0276124-A2 | Prostaglandin derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1988-07-27 | — | — | EP | disclosed |
| EP-0095836-B1 | AZA-FUROCHROMONES | THE UPJOHN COMPANY (US) | 1986-08-13 | — | — | EP | disclosed |
| EP-0099172-B1 | 6,7-DIHYDRO-7,7-DISUBSTITUTED-KHELLINS | THE UPJOHN COMPANY (US) | 1986-08-06 | — | — | EP | disclosed |
| US-4434295-A | Anti-atherosclerotic 6,7-dihydro-7,7-disubstituted-khellin analogs | THE UPJOHN COMPANY (US) | 1984-02-28 | — | — | US | disclosed |
| US-4412071-A | Antiatherosclerotic compositions | THE UPJOHN COMPANY (US) | 1983-10-25 | — | — | US | disclosed |